Early Carbon Dioxide Laser Therapy for Alleviation of Incisional Scar Burden



Status:Recruiting
Healthy:No
Age Range:21 - 80
Updated:12/26/2018
Start Date:November 15, 2017
End Date:August 26, 2019
Contact:Catherine Motosko
Email:Catherine.Motosko@med.nyu.edu
Phone:646 501 4480

Use our guide to learn which trials are right for you!

This is a prospective, randomized pilot study of patients who will undergo either early or
late incisional laser therapy after breast reduction surgery to alleviate scar burden at NYU
Langone Medical Center. The purpose of this study is to see how well carbon dioxide (CO2)
laser therapy works at preventing scar formation after surgery.CO2 laser therapy is currently
being used by dermatologists and plastic surgeons to help with scarring after acne and to
rejuvenate the face; its benefits are now being explored by medical professionals in
dermatology and cosmetic surgery to prevent scarring after surgery.


Inclusion Criteria:

- Patients of all ethnic origins will be considered, although certain ethnic groups will
be preferentially excluded more than others such as black and South Asian patients due
to our exclusion criteria related to darker skin individuals (see below).

- Patients undergoing bilateral breast reduction surgery

Exclusion Criteria:

- Males will be excluded from this study as male patients rarely undergo breast
reduction surgery. When males do undergo breast reduction surgery for gynecomastia, it
is often unilateral, and is performed with several techniques and incision types that
are not typical employed during female breast reduction. Thus, for this study, only
female patients will be considered (see below).

- Any patient enrolled in this study who shows evidence of delayed wound healing,
dehiscence, or post operative infection at the first post operative visit will be
excluded

- Patients with darker skin (Fitzpatrick IV and above), which is a well-known
contraindication to laser therapy

- Pregnant patients

- Patients who have had prior breast surgery

- Patients who have had prior chest/breast irradiation

- Patients with the following diseases which interferes with wound healing: prior
hypertrophic scarring/keloids, type I or type II Diabetes Mellitus, autoimmune
diseases/collagen vascular diseases

- Patients who are active smokers

- Patients using blood thinners that cannot be stopped

- Patients who have used aspirin within a week of the procedure date
We found this trial at
1
site
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Alexes Hazen, MD
Phone: 646-501-4480
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials